Fresenius Medical Care AG Statistics

Total Valuation

LON:0H9X has a market cap or net worth of GBP 10.57 billion. The enterprise value is 19.86 billion.

Market Cap	10.57B
Enterprise Value	19.86B

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025.

Earnings Date	May 6, 2025
Ex-Dividend Date	May 23, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	209.46M

Valuation Ratios

The trailing PE ratio is 23.76.

PE Ratio	23.76
Forward PE	n/a
PS Ratio	0.66
PB Ratio	0.81
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.35, with an EV/FCF ratio of 14.24.

EV / Earnings	44.64
EV / Sales	1.20
EV / EBITDA	7.35
EV / EBIT	13.86
EV / FCF	14.24

Financial Position

The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.70.

Current Ratio	1.40
Quick Ratio	0.91
Debt / Equity	0.70
Debt / EBITDA	3.64
Debt / FCF	6.52
Interest Coverage	3.78

Financial Efficiency

Return on equity (ROE) is 4.84% and return on invested capital (ROIC) is 3.58%.

Return on Equity (ROE)	4.84%
Return on Assets (ROA)	2.85%
Return on Invested Capital (ROIC)	3.58%
Return on Capital Employed (ROCE)	5.52%
Revenue Per Employee	143,393
Profits Per Employee	3,989
Employee Count	111,513
Asset Turnover	0.57
Inventory Turnover	6.87

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.85% in the last 52 weeks. The beta is 0.91, so LON:0H9X's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	+6.85%
50-Day Moving Average	44.42
200-Day Moving Average	40.81
Relative Strength Index (RSI)	43.88
Average Volume (20 Days)	118,328

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0H9X had revenue of GBP 15.99 billion and earned 444.84 million in profits. Earnings per share was 1.51.

Revenue	15.99B
Gross Profit	3.93B
Operating Income	1.27B
Pretax Income	874.05M
Net Income	444.84M
EBITDA	1.94B
EBIT	1.27B
Earnings Per Share (EPS)	1.51

Full Income Statement

Balance Sheet

The company has 1.11 billion in cash and 9.10 billion in debt, giving a net cash position of -7.99 billion.

Cash & Cash Equivalents	1.11B
Total Debt	9.10B
Net Cash	-7.99B
Net Cash Per Share	n/a
Equity (Book Value)	13.04B
Book Value Per Share	41.08
Working Capital	1.87B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.97 billion and capital expenditures -578.35 million, giving a free cash flow of 1.39 billion.

Operating Cash Flow	1.97B
Capital Expenditures	-578.35M
Free Cash Flow	1.39B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 24.60%, with operating and profit margins of 7.96% and 2.78%.

Gross Margin	24.60%
Operating Margin	7.96%
Pretax Margin	5.47%
Profit Margin	2.78%
EBITDA Margin	12.14%
EBIT Margin	7.96%
FCF Margin	8.72%

Dividends & Yields

This stock pays an annual dividend of 1.02, which amounts to a dividend yield of 2.45%.

Dividend Per Share	1.02
Dividend Yield	2.45%
Dividend Growth (YoY)	4.78%
Years of Dividend Growth	1
Payout Ratio	64.91%
Buyback Yield	n/a
Shareholder Yield	2.45%
Earnings Yield	4.21%
FCF Yield	13.20%

Dividend Details

Stock Splits

The last stock split was on June 18, 2007. It was a forward split with a ratio of 3.

Last Split Date	Jun 18, 2007
Split Type	Forward
Split Ratio	3

Scores

LON:0H9X has an Altman Z-Score of 1.65. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	n/a